BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Some chemotherapies, including docetaxel, are better tolerated and just as effective when
giving the dose weekly rather than on an every three week basis. The purpose of this study is
to compare 2 schedules of combination chemotherapy with docetaxel for the effects on quality
of life. Standard every three week chemotherapy will be compared with weekly chemotherapy for
metastatic or locally advanced breast cancer.